Predicting early lung disease in children and young adults after stem cell transplant
Official title: Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11092102 · Data updated 2026-11-12
This work aims to find better ways to screen for and predict a serious lung condition called bronchiolitis obliterans syndrome (BOS) in children and young adults who have had a stem cell transplant.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | July 15, 2021 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $620,085 |
| NIH project number | 5R01HL153108-05 |
| Project ID | NIH-11092102 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is relevant for children and young adults who have received a hematopoietic stem cell transplant and are at risk for or have developed bronchiolitis obliterans syndrome.
✕Less likely to help
Patients who have not undergone a hematopoietic stem cell transplant or are not at risk for bronchiolitis obliterans syndrome would not directly benefit from this specific research.
What this research studies
Bronchiolitis obliterans syndrome (BOS) is a severe lung disease that can happen after a stem cell transplant, and it's often caught too late in children. Our goal is to develop new tools, like blood tests and prediction models, to find BOS much earlier. We will look at specific proteins in blood samples from both children and adults to see if they can predict who is at risk. This will help doctors make better treatment decisions and potentially prevent the disease from getting worse.
Why it matters
Potential benefit: If successful, this work could lead to earlier diagnosis and treatment for bronchiolitis obliterans syndrome, potentially improving survival and reducing long-term health problems for patients.
How similar studies have gone: This work is entirely novel, as there are currently no established biomarkers or predictive tools for bronchiolitis obliterans syndrome.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Myers, Kasiani — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Myers, Kasiani
Related research
Other NIH-funded projects on the same topics.
-
Lymphatic changes after lung transplant and risk of bronchiolitis obliterans
Researchers are looking at how damage or repair of the lung's lymphatic vessels after transplant affects the chance of developing bronchiolitis obliterans in people who receive lung transplants.
-
How respiratory viruses affect long-term lung damage after donor stem cell transplant
Following people who had donor stem cell transplants to see how common respiratory viruses relate to long-term lung damage called bronchiolitis obliterans syndrome.
-
Understanding how lymphatic dysfunction leads to lung complications after transplant
This study is looking at how problems with the lymphatic system might lead to a serious lung issue called bronchiolitis obliterans syndrome (BOS) after a lung transplant, and it aims to find ways to protect against this condition for patients who have had a transplant.
-
Investigating how respiratory viruses affect lung health in transplant patients
This study is looking at how respiratory viruses affect lung health in people who have had a stem cell transplant and are dealing with bronchiolitis obliterans syndrome, and it will use home devices to keep track of their lung function over time to help catch any problems early.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
-
Innate and Adaptive Immunoregulation in Liver Transplant Ischemia/Reperfusion Injury
A liver transplant-focused project investigates how the body’s early and later immune responses affect transplant failure or success after reperfusion.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.